HDAC6 and rhabdomyolysis: Other inhibitors of HDAC6, 23BB and F7, also improved the renal function in the cisplatin and the rhabdomyolysis models by reducing apoptosis, decreasing ER stress, and generally suppressing the inflammatory response [21,26].